Comparative analysis of the PCA3 gene expression in sediments and exosomes isolated from urine
- Authors: Mikhaylenko D.S.1, Novikov A.A.2, Grigor’eva M.V.2, Efremov G.D.2, Sivkov A.V.2, Safronova N.Y.2, Sorokin K.S.3, Zemskova M.Y.4, Nemtsova M.V.5, Alekseev B.Y.2, Kaprin A.D.2
-
Affiliations:
- N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia Institute of Molecular Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia Research Center for Medical Genetics
- N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
- Prostagnost Company
- Prostagnost Company G.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms
- Institute of Molecular Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
- Issue: Vol 13, No 3 (2017)
- Pages: 54-60
- Section: PROSTATE CANCER
- Published: 30.09.2017
- URL: https://oncourology.abvpress.ru/oncur/article/view/685
- DOI: https://doi.org/10.17650/1726-9776-2017-13-3-54-60
- ID: 685
Cite item
Full Text
Abstract
Introduction. Prostate cancer (PCa) is one of the common oncological diseases in men. Expression of the PCA3 gene in urine is currently used as a molecular genetic marker of PCa.
Objective: to comparative analysis of the PCA3 expression in urine sediments and exosomes for the determination of the biomaterial, which allows detecting the PCA3 expression in more efficient manner.
Materials and methods. The 12 patients with different stages of PCa and 8 control samples were examined.
Results. The diagnostic accuracy of the PCA3 gene expression analysis in this cohort exceeded 90 %. We had not obtained significant differences in the sensitivity and specificity of the PCA3 hyperexpression in the urine sediments compared with exosomes. This result indicates in favor to using urine sediment for the PCA3 analysis as a biomaterial with less time-consuming sample preparation, although the possible advantage of exosomes for the analysis of the expression marker panels requires further studies.
Keywords
About the authors
D. S. Mikhaylenko
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of RussiaInstitute of Molecular Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Research Center for Medical Genetics
Author for correspondence.
Email: dimserg@mail.ru
ORCID iD: 0000-0001-9780-8708
Build. 4, 51 3rd Parkovaya St., Moscow 105425, Russia
Build. 2, 8 Trubetskaya St., Moscow 119991, Russia
1 Moskvorech’e St., Moscow 115478, Russia
Russian Federation
A. A. Novikov
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Email: urologist.mch70@gmail.com
Build. 4, 51 3rd Parkovaya St., Moscow 105425, Russia Russian Federation
M. V. Grigor’eva
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Email: grinyamary@gmail.com
Build. 4, 51 3rd Parkovaya St., Moscow 105425, Russia Russian Federation
G. D. Efremov
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Email: efremov.gen@yandex.ru
Build. 4, 51 3rd Parkovaya St., Moscow 105425, Russia Russian Federation
A. V. Sivkov
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Email: uroinfo@yandex.ru
Build. 4, 51 3rd Parkovaya St., Moscow 105425, Russia Russian Federation
N. Yu. Safronova
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Email: nisa55@mail.ru
Build. 4, 51 3rd Parkovaya St., Moscow 105425, Russia Russian Federation
K. S. Sorokin
Prostagnost Company
Email: konst.sorokin@gmail.com
7 Nobelya St., Skolkovo district, Moscow 143026, Russia Russian Federation
M. Yu. Zemskova
Prostagnost CompanyG.K. Skryabin Institute of Biochemistry and Physiology of Microorganisms
Email: marinazemskova9@gmail.com
7 Nobelya St., Skolkovo district, Moscow 143026, Russia
5 Prospekt Nauki, Pushchino, Moscow region 142290, Russia
Russian FederationM. V. Nemtsova
Institute of Molecular Medicine, I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Email: nemtsova_m_v@mail.ru
Build. 2, 8 Trubetskaya St., Moscow 119991, Russia Russian Federation
B. Ya. Alekseev
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Email: byalekseev@mail.ru
Build. 4, 51 3rd Parkovaya St., Moscow 105425, Russia Russian Federation
A. D. Kaprin
N.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of the National Medical Research Radiological Center, Ministry of Health of Russia
Email: info@mnioi.ru
Build. 4, 51 3rd Parkovaya St., Moscow 105425, Russia Russian Federation
References
Supplementary files

